NHEJ1 (Non-Homologous End Joining Factor 1), also known as XLF or Cernunnos, is a gene located on chromosome 2q33.3 that encodes a core component of the non-homologous end joining (NHEJ) DNA repair pathway. NHEJ is the primary mechanism for repairing DNA double-strand breaks (DSBs) in mammalian cells and is essential for V(D)J recombination in lymphocyte development. Mutations in NHEJ1 cause a severe immunodeficiency syndrome, and defective NHEJ is associated with increased genomic instability and cancer risk. Recent research suggests NHEJ dysfunction may also contribute to neurodegeneration.
The protein encoded by NHEJ1 is available at [NHEJ1 Protein](/proteins/nhej1-protein).
Function
Normal Physiological Functions
NHEJ1 forms a complex with XRCC4 and DNA ligase IV to complete the final ligation step in NHEJ repair:
DNA double-strand break repair: Joins DNA ends that lack homologous sequences
V(D)J recombination: Essential for antigen receptor gene rearrangement in B and T cells
Telomere maintenance: Involved in alternative lengthening of telomeres
Genomic stability: Prevents chromosomal translocations and deletions
Brain Expression
NHEJ1 is expressed in multiple brain regions:
Cerebral [cortex](/brain-regions/cortex) ([neurons](/entities/neurons) and glial cells)
[Hippocampus](/brain-regions/hippocampus)
Cerebellum (Purkinje cells)
Germinal zones during development
Expression is generally ubiquitous, with higher levels in proliferating cells.
Role in Neurodegeneration
DNA Damage Accumulation
NHEJ deficiency leads to progressive DNA damage accumulation in post-mitotic neurons:
Neurons accumulate DNA double-strand breaks over time
Impaired repair leads to genomic instability
DNA damage triggers apoptotic pathways
Connection to Ataxia-Telangiectasia
NHEJ1 interacts with ATM (Ataxia-Telangiectasia Mutated) kinase:
ATM activates DNA damage checkpoints
Combined defects cause severe neurodegeneration
Ataxia-telangiectasia patients show progressive cerebellar degeneration
Parkinson's Disease
Recent studies suggest NHEJ dysfunction may contribute to PD:
Dopaminergic neurons are particularly vulnerable to DNA damage
Mitochondrial DNA damage may be especially relevant
PARP1 hyperactivation can deplete NAD+ and energy reserves
Aging and Neurodegeneration
DNA repair capacity declines with age:
NHEJ efficiency decreases in aging neurons
Accumulated damage contributes to age-related neurodegeneration
Therapeutic enhancement of NHEJ may have anti-aging effects
Disease Associations
Ataxia-Telangiectasia-Like Disorder (ATLD)
Caused by NHEJ1 mutations
Milder than AT due to partial NHEJ function
Cerebellar ataxia and immunodeficiency
Parkinson's Disease
NHEJ1 variants may modify PD risk
DNA damage response pathways are impaired in PD brains
Interaction with PINK1/Parkin mitophagy pathways
Cancer
NHEJ1 deficiency increases cancer risk
Chromosomal translocations are more frequent
Particularly important in lymphoid malignancies
Therapeutic Implications
DNA Repair Enhancement
Targeting NHEJ may offer therapeutic benefits:
Small molecules to enhance NHEJ efficiency
Gene therapy to restore NHEJ1 function
Antioxidants to reduce oxidative DNA damage
Neuroprotection
Strategies for neuroprotection include:
PARP inhibitors to prevent excessive energy depletion
NAD+ supplementation to support DNA repair
Mitochondrial-targeted antioxidants
Key Publications
[Cernunnos/XLF regulates the kinetics of DNA end joining](https://doi.org/10.1016/j.cell.2006.05.028). Cell, 2006. PMID: 16809985(https://pubmed.ncbi.nlm.nih.gov/16809985/)
[Non-homologous end joining and neurodegenerative disease](https://doi.org/10.1016/j.dnarep.2020.102893). DNA Repair, 2020. PMID: 32771837(https://pubmed.ncbi.nlm.nih.gov/32771837/)
[DNA damage and repair in neurodegeneration](https://doi.org/10.1016/j.neurobiolaging.2019.01.003). Neurobiology of Aging, 2019. PMID: 30639256(https://pubmed.ncbi.nlm.nih.gov/30639256/)